Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
9.60 in minutes
AKTX
AKTX!!!! WHHHOOO!!! JUST BANKED 200K MORE!!!!! MBD
The way it is climbing, we could see that before the opening bell!!!
YES with
big if....
AKTX 9.60 WOOOOOOW
At this rate if no offering we could see $15 today
You got that right buddy.
We are going to hit $9.00 premarket.
Good example of over analysis leading to paralysis.
AKTX > Continues amazing run.
$7 break.... LOOKIN STRONG
JUST AS LONG AS AKTX DOESNT PULL A BPTH OFFERING
Incredible BUYING pouring in now PM
Dino,
Are you right or wrong on the $8.00 Pre market???????
I see they targeting C5 , alexion already tried with soliris , dident work. Not bashing , just saying
No wonder with the huge move. I can see another boom tomorrow
current treatment for PNH is Eculizulab cost at least $450,000 - $500,000 a year for each patient , reported as one of the most expensive drugs.
Thanks for all the congrats! Ran out of posts!! Congrats 2u all as well! More to comeMBD
Yeah I kept watching it at around 70% up and saying no. But, I eventually jumped in and did OK.
It looks like it has more left in it. IMO.
Be careful this is insane. I was going to get in at 3.80 when it was 80-100% and decided nope may only get up another 20-30% boy was I wrong ????????
Lol wtf? This is nasdaq half a billion $ volume - clay has no influence here
Sorry Clay, have to disagree on the after hours close, this thing went as high as 7.03, but it closed at 6.85, not like you said 6.55.
Just for the record I anticipate this opening above $8.00 and possibly hitting $9.00 premarket and provided no offering comes in premarket.
going to 3.5 day 3 careful guys this aint going to 9 or 13... might gap a bit and tick the retail money and then stright down again.
Day 2 short ville.
www.fusz.yolasite.com
has cash problems
needs partners
drug may have unaddressed side effects as inferred from their disclaimer
oversold and ready for shorts to pile in and myself EOD 4 and tomorrow 2.8
fundamentals are negative and their is no real product..
product has limited marketing value given rarity of disease and questions remain whether the drug is signficantly better than the placebo. and whether the death of a person involved in the study could have been affected by the drug is not fully explored in my opinion. its 67% success rate needs to be qualified against the backdrop of ineffective treatments..for example a simple discontinuation of the previous treatment under placebo would that beat their 67% figure... probably since they did not relay the actual figures to properly quantify and clarify whether this could be the case.
the price only up so much because of well timed news and low float enthusiasts and pumpers. be warned professionals have to now clean up the party.
* * $AKTX Video Chart 03-13-2019 * *
Link to Video - click here to watch the technical chart video
Simply awesome!!! Congrats
I am calling for premarket 9.00 dollars, we will shoot to $12 if no offering and straight to 15 dollars. Lot of eyes on this one. Massive buying all the way throughout the day and continued into after hours.
Lets see PM tomorrow should be rocking
Look at the triple digit numbers, you never know you know. By no means I am saying it would shoot up to $40.00, but it could get there in due time. The news as definitely outstanding the market was very receptive.
Now that you mentioned I had to look. http://schrts.co/AXMdSIAQ
That would be really nice to shoot up to $40 again!
Well, this stock at some point was triple digits and at the time, they didn't even the news we had today. If they thought the valuation then was worth in triple digits, then there is definitely potential. How much potential? We will let the market speak for the valuation. Of-course the share structure must have been lower then, by not much, but at least lower, more importantly, my predictions and analysis is provided there is no offering tomorrow premarket, if no offering, then we could easily breeze through 15 dollars.
Let's see what tomorrow brings! NEW YORK and LONDON, March 13, 2019 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (AKTX), a biopharmaceutical company focused on innovative therapeutics to treat orphan autoimmune and inflammatory diseases where the complement and/or leukotriene systems are implicated, announces that it had a successful Type B, pre-IND meeting with the Food and Drug Administration (FDA) regarding Akari’s proposed pivotal clinical trial program for pediatric hematopoietic stem cell transplant-related thrombotic microangiopathy (HSCT-TMA). HSCT-TMA is an orphan condition with an estimated fatality rate of more than 80% in children with the severe disease.1
I hope history repeats itself
Here is a history on this ticker, back in 2015 the stock shot up from $10 to $45 dollars in a single day and the next day it ran to $60.00. I also have to consider the fact that the float must have smaller than what we have here today, but it is definitely possible that we hit $10.00 or even higher, now again, provided that there is no offering, if no offering it could run to $15 after $11.50 resistance is broken. Good luck and if you are considering it have an exit strategy in place, it could get really wild.
Yes you will, good luck! Big boys will start jumping in tomorrow. IMHO.
Best of luck . hoping for a dip here . if not I'll catch up on next runner
I sold all before market closed, then the way it was acting I bought back after hours for a strong opening it looks like.
I'm hoping for that and very possible the way it closed and kept going after market.
If it runs a 2nd day. It could see $12
Around 2pm to 3pm. I'm jumping back in in am if it dips. I don't hold overnight . just a personal rule.
More OS shares = shelf placement offering.
Define "offering" please. What am I missing?? Just getting caught up on the day.
It shows that $7.03 hit after hours, when were the halts, I wasn't around I guess.
All the resistances were broken, especially after-hours 8.65, the next resistance is 11.50 once that goes through, provided that there is no offering premarket and generally bio do a premarket or aftermarket offering, it could go past $15. But my personal target is $10.00
The way you wrote your original post I mis-understood it to read a secondary offering was imminent.
Wouldn't that be outstanding if we could bounce off 20 tomorrow.
Thank you so much for the clarity.
When do you a secondary offering Direct or public offering, Direct offering is for institutions and public offering is for the public, sort of speak, dilution. So if they sell shares into the market place, you as a shareholder will get diluted. They could do an offering whether direct or public for lets assume the share price blasted through $10.00 tomorrow and they did offering for $8.00 so essentially you got diluted if you paid $10.00 the stock will drop to around $8.00 or even lower because of panic selling, but eventually the stock will keep rising. They do that do raise money for corporate payrolls and clinical trials, FDA fees, etc...etc.... but end the end if you believe the science it shouldn't matter, cause the stock will go up at some point, definitely will take time, but it will probably to 20...30..... It all depends how much the market values their science and believes in it. The volume speaks for itself and after hours volume also speaks to what is going to happen tomorrow, now if no dilution this could potentially hit $20 tomorrow.
When do you a secondary offering Direct or public offering, Direct offering is for institutions and public offering is for the public, sort of speak, dilution. So if they sell shares into the market place, you as a shareholder will get diluted. They could do an offering whether direct or public for lets assume the share price blasted through $10.00 tomorrow and they did offering for $8.00 so essentially you got diluted if you paid $10.00 the stock will drop to around $8.00 or even lower because of panic selling, but eventually the stock will keep rising. They do that do raise money for corporate payrolls and clinical trials, FDA fees, etc...etc.... but end the end if you believe the science it shouldn't matter, cause the stock will go up at some point, definitely will take time, but it will probably to 20...30..... It all depends how much the market values their science and believes in it. The volume speaks for itself and after hours volume also speaks to what is going to happen tomorrow, now if no dilution this could potentially hit $20 tomorrow.
Define "offering" please. What am I missing?? Just getting caught up on the day.
It all depends if no offering comes in tomorrow.
Hate when that happens
Followers
|
13
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
553
|
Created
|
09/21/15
|
Type
|
Free
|
Moderators |
Akari is focused on developing inhibitors of acute and chronic inflammation, specifically the complement system, and leukotriene system,
for the treatment of rare and orphan diseases with unmet need. We believe that blocking early mediators of inflammation
will prevent initiation and continual amplification of the processes that cause certain diseases.
Nomacopan is a recombinant small protein (16,740 Da) that acts on complement component-C5,
preventing release of C5a and formation of C5b–9 (also known as the membrane attack complex, or MAC),
and independently also inhibits leukotriene B4, or LTB4, activity, both elements that are co-located as part of the immune/inflammatory response.
Nomacopan is currently being clinically evaluated in four indications:
Akari believes that the dual action of nomacopan on both C5 and LTB4 may be beneficial in AKC, BP, and aHUS. Akari is also developing other tick derived proteins, including longer acting versions.
Nomacopan is a highly soluble and stable biological molecule, and independently binds to both C5 and LTB4. This novel dual binding enables targeting of two distinct and separate disease categories based on their underlying etiology.
July 1, 2020
July 1, 2020
June 1, 2020
May 1, 2020
March 31, 2020
Patients with COVID-19 pneumonia
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |